2026 NPPES data Glaucoma Specialist (Ophthalmology) Physician NPI 1285657031 MD
Verify on CMS →

STEPHEN RECK, MD

Glaucoma Specialist (Ophthalmology) Physician in LACEY, Washington. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
4K
Medicare Part D claims · 606 beneficiaries · Glaucoma Specialist (Ophthalmology) Physician avg: 3K
Generic prescribing
68%
generic claims · 32% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
91.5435/100
▲ 8 pts above national avg 83.1 · [object Object]
Industry payments
$159.69
8 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

STEPHEN RECK, MD reported a CMS MIPS final score of 91.5435/100 — above the 83.1 national average — and filed 4,414 Medicare Part D claims in 2023.

91.5435/100
MIPS score · +8 vs avg
4K
Part D claims, 2023
68%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

STEPHEN RECK, MD's MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

92 Top 37% higher than 63% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). Below this entry. 90–100: 189,403 scored providers (40%). This entry sits in this band. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

STEPHEN RECK, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about STEPHEN RECK, MD?

High performer (top quartile)

NPI registry status

Active

Issued 07/25/2006

NPI 1285657031

Primary specialty

Glaucoma Specialist (Ophthalmology) Physician

Rare

354 US NPIs in this specialty

Medicare Part D claims

4,414 49% vs specialty avg

2023 prescription claims

Specialty avg: 2,962

MIPS final score

91.5435/100 8.4435% pts

Exceptional band

vs 83.1 national avg

Specialty distribution in Washington

How Glaucoma Specialist (Ophthalmology) Physician compares to other specialties among Washington providers

Washington providers

Glaucoma Specialist (Ophthalmology) Physician share within Washington

1. Glaucoma Specialist (Ophthalmology) Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Glaucoma Specialist (Ophthalmology) Physician share within Washington

Medicare quality performance — MIPS

STEPHEN RECK, MD's 2023 MIPS final score plotted against the Glaucoma Specialist (Ophthalmology) Physician national average

High performer (top quartile)
MIPS Final Score
91.5435/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Glaucoma Specialist (Ophthalmology) Physician) — 91.5435/100 vs national avg 83.1

0%100%National avg83%91.5%
MIPS final score (Glaucoma Specialist (Ophthalmology) Physician) — 91.5435/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

STEPHEN RECK, MD appears in the CMS NPPES registry as a Glaucoma Specialist (Ophthalmology) Physician provider holding MD credentials at 345 COLLEGE ST SE, LACEY, WA, 98503, with a listed phone of (360) 456-3200. NPI 1285657031 was issued on 07/25/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what RECK most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 4,414 prescription claims written by this provider, covering 606 Medicare beneficiaries and totaling roughly $468K in drug spend, split 32% brand-name and 68% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 91.5435/100 for the 2023 performance year (Quality 100, Cost 71.8116), compared with the national average of 83.1.

Glaucoma Specialist (Ophthalmology) Physician is a narrow specialty nationwide, with 354 enrolled providers across 42 states and an average of 2,962 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

345 COLLEGE ST SE
LACEY, WA 98503

Provider Details

NPI 1285657031
Specialty Glaucoma Specialist (Ophthalmology) Physician
Credentials MD
Gender Male
NPI Issued 07/25/2006

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

91.5435
Final Score
Avg: 83.1
100
Quality
71.8116
Cost

Reporting: Group practice

Hospital and facility affiliations

Facilities where STEPHEN RECK, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

EYE PHYSICIANS OF OLYMPIA INC PS
LACEY, WA

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for STEPHEN RECK, MD. Source: openpaymentsdata.cms.gov.

Total received

$160

Largest payer

Alcon Vision LLC

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Washington WMC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~34K Washington medical licensees in 2023 — they are NOT specific to STEPHEN RECK, MD. To verify STEPHEN RECK, MD's current license status, search the WMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

88
Total board actions, Washington 2023
Across 85 cases
2.59
Actions per 1,000 licensees
Washington statewide rate
probation
Most common action type
31 cases

WMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Washington disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

STEPHEN RECK, MD — brand share 32.0%
Specialty average (est.)

32% brand-name claims vs 68% generic, on 4,414 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

4,414
Total Claims
$468K
Total Drug Cost
606
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
7,938
Total Day Supply
229,384
Brand vs Generic
32% brand / 68% generic
Brand Drug Cost
$333K
Generic Drug Cost
$135K

Patient Demographics

Average Patient Age
77.5 years
Avg HCC Risk Score
1.17
Gender Split
56% female / 44% male
Age Distribution
<65: 11, 65-74: 226, 75-84: 250, 85+: 119

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What STEPHEN RECK, MD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Latanoprost
1,234
Dorzolamide-Timolol
Dorzolamide Hcl/Timolol Maleat
577
Brimonidine Tartrate
463
Dorzolamide Hcl
339
Timolol Maleate
339
Prednisolone Acetate
191
Rhopressa
Netarsudil Mesylate
184
Ofloxacin
100
Lumigan
Bimatoprost
95
Travoprost
91

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Glaucoma Specialist (Ophthalmology) Physician Overview

How STEPHEN RECK, MD fits within the Glaucoma Specialist (Ophthalmology) Physician landscape nationally.

354
Glaucoma Specialist (Ophthalmology) Physician Providers in US
42
States with Glaucoma Specialist (Ophthalmology) Physician
2,962
Avg Claims per Provider

STEPHEN RECK, MD's 4,414 claims are above the specialty average of 2,962.

Nearby Glaucoma Specialist (Ophthalmology) Physician Providers in Washington

Other clinicians with the same primary specialty enrolled in Washington, drawn from the same CMS NPPES roster as RECK.

Compare Glaucoma Specialist (Ophthalmology) Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is STEPHEN RECK, MD's specialty?
STEPHEN RECK, MD specializes in Glaucoma Specialist (Ophthalmology) Physician and practices in LACEY, Washington. Credentials: MD.
How much does STEPHEN RECK, MD prescribe under Medicare Part D?
In 2023, STEPHEN RECK, MD wrote 4,414 Medicare Part D claims totaling $468K in drug costs for 606 beneficiaries.
What is STEPHEN RECK, MD's Medicare quality score?
STEPHEN RECK, MD has a CMS MIPS Final Score of 91.5435/100 (Quality: 100, Cost: 71.8116). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is STEPHEN RECK, MD located?
STEPHEN RECK, MD is located at 345 COLLEGE ST SE, LACEY, WA, 98503. Phone: (360) 456-3200.
What is STEPHEN RECK, MD's NPI number?
STEPHEN RECK, MD's National Provider Identifier (NPI) is 1285657031, issued on 07/25/2006.
Does STEPHEN RECK, MD prescribe more brand-name or generic drugs?
STEPHEN RECK, MD's prescribing is 32% brand-name and 68% generic drugs by claim count, with $333K in brand drug costs.
How many Glaucoma Specialist (Ophthalmology) Physician providers are there in the US?
There are 354 Glaucoma Specialist (Ophthalmology) Physician providers across 42 states in the US. The average Glaucoma Specialist (Ophthalmology) Physician provider writes 2,962 Medicare Part D claims per year.
What drugs does STEPHEN RECK, MD prescribe most often?
Based on 2023 Medicare Part D data, STEPHEN RECK, MD's most frequently prescribed drugs include Latanoprost, Dorzolamide-Timolol, Brimonidine Tartrate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does STEPHEN RECK, MD accept Medicare?
STEPHEN RECK, MD appears in CMS Medicare data with 4,414 Part D claims and 606 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify STEPHEN RECK, MD's credentials?
STEPHEN RECK, MD's NPI is 1285657031 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology